The FDA has approved Journavx, a groundbreaking non-opioid painkiller, marking the first new class in over 20 years, aiming to eliminate the risks of opioid addiction.
People increasingly use weight-loss medications to manage compulsive eating urges, gaining relief from persistent food noise and improving their eating habits.